Lv6
2350 积分 2022-01-13 加入
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan, and South Korea with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial
2天前
求助中
Brief report: Ivonescimab combined with etoposide plus carboplatin as first-line treatment for extensive-stage small-cell lung cancer: results of a phase Ib clinical trial
13天前
已完结
520LBA (PB-520) LBA Posters: Preclinical characterization of LY4175408, a novel PTK7 targeting antibody-drug conjugate, utilizing exatecan via a hydrophilic polysarcosine linker platform
15天前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
15天前
已完结
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
20天前
已完结
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
1个月前
已完结
Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis
1个月前
已完结
Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis
1个月前
已完结
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review
1个月前
已完结
B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production
1个月前
已完结
皖公网安备34019202002308
